TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for

Reinhard Dummer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.